DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $80,439,230 | +3.7% | 324,221 | +0.3% | 0.36% | +9.1% |
| Q2 2023 | $77,560,800 | -2.2% | 323,170 | +2.7% | 0.33% | -8.6% |
| Q1 2023 | $79,300,857 | -4.3% | 314,636 | +1.4% | 0.36% | -11.1% |
| Q4 2022 | $82,828,008 | -1.4% | 310,443 | -4.5% | 0.40% | -5.4% |
| Q3 2022 | $83,999,000 | +2.5% | 325,215 | +0.6% | 0.43% | +10.9% |
| Q2 2022 | $81,920,000 | -12.4% | 323,133 | +1.4% | 0.38% | +5.5% |
| Q1 2022 | $93,501,000 | -16.5% | 318,751 | -7.0% | 0.36% | -6.4% |
| Q4 2021 | $112,004,000 | +6.1% | 342,881 | -1.1% | 0.39% | -3.7% |
| Q3 2021 | $105,536,000 | +15.0% | 346,652 | +1.3% | 0.40% | +18.4% |
| Q2 2021 | $91,809,000 | +13.6% | 342,105 | -4.8% | 0.34% | +6.5% |
| Q1 2021 | $80,853,000 | -1.3% | 359,222 | -2.2% | 0.32% | -4.7% |
| Q4 2020 | $81,887,000 | +5.1% | 367,474 | +1.6% | 0.34% | -5.9% |
| Q3 2020 | $77,886,000 | +20.5% | 361,702 | -1.1% | 0.36% | +12.6% |
| Q2 2020 | $64,648,000 | +31.1% | 365,591 | +2.6% | 0.32% | +10.4% |
| Q1 2020 | $49,325,000 | -20.1% | 356,356 | -11.4% | 0.29% | +3.6% |
| Q4 2019 | $61,712,000 | +6.9% | 402,088 | +0.6% | 0.28% | 0.0% |
| Q3 2019 | $57,704,000 | +12.0% | 399,522 | +10.8% | 0.28% | +9.9% |
| Q2 2019 | $51,524,000 | +15.3% | 360,513 | +6.5% | 0.25% | +4.5% |
| Q1 2019 | $44,696,000 | -58.4% | 338,551 | -67.5% | 0.24% | -5.5% |
| Q4 2018 | $107,372,000 | -6.8% | 1,042,670 | -1.7% | 0.26% | +8.5% |
| Q3 2018 | $115,156,000 | +11.6% | 1,060,233 | +1.4% | 0.24% | +4.9% |
| Q2 2018 | $103,159,000 | +1.5% | 1,045,460 | +0.7% | 0.22% | -1.7% |
| Q1 2018 | $101,603,000 | +6.3% | 1,037,713 | +0.9% | 0.23% | +8.5% |
| Q4 2017 | $95,556,000 | +7.1% | 1,028,703 | -1.2% | 0.21% | +1.0% |
| Q3 2017 | $89,217,000 | +1.2% | 1,040,951 | -0.4% | 0.21% | -7.1% |
| Q2 2017 | $88,169,000 | -0.0% | 1,045,179 | +1.4% | 0.22% | -3.0% |
| Q1 2017 | $88,201,000 | +3.1% | 1,031,024 | -6.1% | 0.23% | +5.9% |
| Q4 2016 | $85,540,000 | +848.1% | 1,098,306 | +840.5% | 0.22% | +63.4% |
| Q3 2016 | $9,022,000 | -20.8% | 116,785 | +2.7% | 0.13% | -21.6% |
| Q2 2016 | $11,393,000 | +5.3% | 113,701 | -0.2% | 0.17% | +8.2% |
| Q1 2016 | $10,820,000 | +2.0% | 113,888 | +0.9% | 0.16% | 0.0% |
| Q4 2015 | $10,605,000 | +23.6% | 112,818 | +9.8% | 0.16% | +20.6% |
| Q3 2015 | $8,577,000 | +2.1% | 102,764 | +3.8% | 0.13% | +12.9% |
| Q2 2015 | $8,400,000 | -10.0% | 98,995 | -9.3% | 0.12% | +0.9% |
| Q1 2015 | $9,329,000 | -7.4% | 109,113 | -6.1% | 0.12% | -12.2% |
| Q4 2014 | $10,073,000 | +3.1% | 116,166 | -9.9% | 0.13% | -3.0% |
| Q3 2014 | $9,773,000 | -20.6% | 128,916 | -17.1% | 0.14% | -26.6% |
| Q2 2014 | $12,306,000 | -7.6% | 155,494 | -13.6% | 0.18% | -12.4% |
| Q1 2014 | $13,316,000 | -16.5% | 180,007 | -13.0% | 0.21% | -15.0% |
| Q4 2013 | $15,943,000 | +3.0% | 206,898 | -6.6% | 0.25% | +6.0% |
| Q3 2013 | $15,472,000 | +19.5% | 221,586 | +8.9% | 0.23% | +11.0% |
| Q2 2013 | $12,944,000 | – | 203,456 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |